A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment
暂无分享,去创建一个
S. Schölch | Kristin Werner | D. Stange | A. Ramírez de Molina | Silvia Cruz-Gil | Ruth Sánchez-Martínez | Sonia Wagner-Reguero
[1] X. Shu,et al. Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer , 2018, Cancer research and treatment : official journal of Korean Cancer Association.
[2] Mechthild Krause,et al. Human gastric cancer modelling using organoids , 2018, Gut.
[3] X. Tong,et al. Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN , 2018, Journal of experimental & clinical cancer research : CR.
[4] S. Bonin,et al. Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients. , 2018, Molecular and clinical oncology.
[5] M. Gariboldi,et al. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production , 2017, Scientific Reports.
[6] J. Herranz,et al. Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role[S] , 2017, Journal of Lipid Research.
[7] C. Liang,et al. Prognostic value of high-expression of miR-17-92 cluster in various tumors: evidence from a meta-analysis , 2017, Scientific Reports.
[8] J. Górski,et al. Effect of metformin on bioactive lipid metabolism in insulin-resistant muscle. , 2017, The Journal of endocrinology.
[9] Teng Han,et al. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer , 2017, Nature Biotechnology.
[10] I. Bijsmans,et al. Characterization of stem cell-derived liver and intestinal organoids as a model system to study nuclear receptor biology. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[11] Tiago Grego,et al. One-step generation of conditional and reversible gene knockouts , 2017, Nature Methods.
[12] R. A. Igal,et al. Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism. , 2016, Biochimica et biophysica acta.
[13] R. Riechelmann,et al. Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer. , 2016, Clinical colorectal cancer.
[14] M. Arends,et al. Molecular pathological classification of colorectal cancer , 2016, Virchows Archiv.
[15] M. Lai,et al. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer , 2016, PloS one.
[16] Alyssa J. Miller,et al. How to Grow a Lung: Applying Principles of Developmental Biology to Generate Lung Lineages from Human Pluripotent Stem Cells , 2016, Current Pathobiology Reports.
[17] A. Harsulkar,et al. Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats , 2016, Genes & Nutrition.
[18] Kristin Werner,et al. Organoids as Model Systems for Gastrointestinal Diseases: Tissue Engineering Meets Genetic Engineering , 2016, Current Pathobiology Reports.
[19] Jie Ren,et al. Stearoyl-CoA desaturase-1 mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis , 2016, Scientific Reports.
[20] Y. Imai,et al. Molecular pathogenesis of sporadic colorectal cancers , 2016, Chinese journal of cancer.
[21] Takla Griss,et al. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis , 2015, PLoS biology.
[22] J. Herranz,et al. A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy , 2015, Oncotarget.
[23] Daniel Golovko,et al. Colorectal cancer models for novel drug discovery , 2015, Expert opinion on drug discovery.
[24] M. Ciorba. Scap and the intestinal epithelial stem cell niche: new insights from lipid biology1 , 2015, Journal of Lipid Research.
[25] Hans Clevers,et al. SnapShot: Growing Organoids from Stem Cells , 2015, Cell.
[26] X. Chen,et al. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn’s disease , 2015, Scientific Reports.
[27] Xuefeng Yang,et al. Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update. , 2015, World journal of gastroenterology.
[28] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[29] M. Spector,et al. Organoid Models of Human and Mouse Ductal Pancreatic Cancer , 2015, Cell.
[30] M. Pollak,et al. Metformin directly acts on mitochondria to alter cellular bioenergetics , 2014, Cancer & metabolism.
[31] H. Nasri,et al. Metformin: Current knowledge , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[32] D. Xie,et al. A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential , 2014, Clinical Cancer Research.
[33] Y. Lu,et al. Overexpression of stearoyl-CoA desaturase 1 in bone marrow mesenchymal stem cells enhance the expression of induced endothelial cells , 2014, Lipids in Health and Disease.
[34] Fang Wang,et al. MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells , 2013, Journal of Cell Science.
[35] J. Tao,et al. Overexpression of stearoyl-CoA desaturase 1 in bone-marrow mesenchymal stem cells increases osteogenesis. , 2013, Panminerva medica.
[36] Hans Clevers,et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration , 2013, Nature.
[37] H. Clevers,et al. Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. , 2012, Gastroenterology.
[38] T. Kim,et al. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus , 2012, International journal of cancer.
[39] D. Simeone,et al. Metformin and Cancer Stem Cells: Old Drug, New Targets , 2012, Cancer Prevention Research.
[40] Hans Clevers,et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.
[41] J. Fargnoli,et al. Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy , 2011, Molecular Cancer Research.
[42] A. Kunthur,et al. Effect of metformin alone and in combination with 5-fluorouracil (5FU), oxaliplatin (O) and irinotecan (I) on human colon cancer cell lines. , 2011, Journal of Clinical Oncology.
[43] Jie Xiang,et al. Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis , 2010, Current genomics.
[44] Hans Clevers,et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. , 2010, Cell stem cell.
[45] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[46] T. Langmann,et al. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. , 2006, Biochimica et biophysica acta.
[47] S. Prescott,et al. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. , 2001, Cancer research.
[48] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.